SEC Form 4 · accession 0000950142-15-001511
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov A Goldstein M.D.
Director
Period of report
Jun 22, 2015
Accepted (ET)
Jun 24, 2015 · 9:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2015 | M | 5,000 | $0.00 | A | 5,050 | D | |
| Common Stock | Jun 22, 2015 | M | 15,000 | $0.00 | A | 20,050 | D | |
| Common Stock | Jun 22, 2015 | M | 15,000 | $0.00 | A | 35,050 | D | |
| Common Stock | Jun 22, 2015 | M | 15,000 | $0.00 | A | 50,050 | D | |
| Common Stock | Jun 22, 2015 | S | 50,000 | $35.74 | D | 50 | D | |
| Common StockF2 | holding | — | — | — | 2,193,110 | I | By Aisling Capital II, LP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF5,F4 | $23.51 | Jun 22, 2015 | M | 5,000 | D | — | Dec 31, 2024 | Common Stock | 5,000 | 10,000 | D |
| Stock Option | $13.10 | Jun 22, 2015 | M | 15,000 | D | Jan 1, 2015 | Jan 7, 2024 | Common Stock | 15,000 | 0 | D |
| Stock Option | $6.79 | Jun 22, 2015 | M | 15,000 | D | Jan 1, 2014 | Feb 3, 2023 | Common Stock | 15,000 | 0 | D |
| Stock Option | $7.62 | Jun 22, 2015 | M | 15,000 | D | Jan 1, 2013 | Mar 20, 2022 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Sold pursuant to 10b5-1 Plan.
- F2The reportable securities are owned directly by Aisling Capital II, LP ("Aisling"), and held indirectly by Aisling Capital Partners, LP ("Aisling GP"), as general partner of Aisling, and Aisling Capital Partners, LLC, as general partner of Aisling GP. Dr. Goldstein is a member of the investment committee of Aisling. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
- F3Exercised pursuant to 10b5-1 Plan.
- F4The option vests on the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning January 1, 2015.
- F5These stock options are held by Dr. Goldstein for the benefit of Aisling Capital LLC. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.